LABORATORY CORP OF AMERICA HOLDINGS (CIK: 0000920148) EDGAR, Information, Filings... CompaniesBIO.Com

LABORATORY CORP OF AMERICA HOLDINGS

Mailing address
358 S MAIN ST, BURLINGTON, Delaware, 27215
Phone
3362291127
State location
North Carolina
State of incorporation
Delaware
Fiscal year end
December 31
SIC
8071 - (CF Office: Office of Life Sciences) SERVICES-MEDICAL LABORATORIES
Filings
N/A

LABORATORY CORP OF AMERICA HOLDINGS (CIK: 0000920148) is an American company incorporated in the state of North Carolina. Head office is located at 358 S MAIN ST, BURLINGTON, North Carolina, 27215. Work in the industry 8071 - (CF Office: Office of Life Sciences) SERVICES-MEDICAL LABORATORIES. LABORATORY CORP OF AMERICA HOLDINGS is a public company and trade via Over-The-Counter (OTC).

Old names:

NATIONAL HEALTH LABORATORIES HOLDINGS INC from 1994-08-Jul to 1995-13-Feb

Owner	Filings	Transaction Date	Type of Owner
Rothman Paul	0001601332	Jun-06-2023	director
DiVincenzo Jonathan P.	0001453524	May-01-2023	officer: EVP, Pres, Central Labs & Intl
Bailey Megan D.	0001975682	May-01-2023	officer: EVP, Chief Strategy Officer
GRAHAM ANITA Z	0001206814	Apr-03-2023	officer: EVP, CHRO
Pike Thomas	0001471570	Jan-09-2023	officer: Pres & CEO Clinical Business
Kliphouse Kirsten Marie	0001948684	Oct-12-2022	director
Wengel Kathryn E	0001745955	Mar-25-2021	director
Summy Amy B.	0001805303	Mar-02-2020	officer: EVP, Chief Marketing Officer
Davis Jeffrey A.	0001648477	Dec-01-2019	director
Schroeder Mark S	0001793112	Nov-05-2019	officer: EVP, President-Diagnostics Lab
Kirchgraber Paul R	0001791393	Nov-01-2019	officer: CEO, Covance Drug Development
Seltz Judith C	0001791228	Oct-15-2019	officer: Chief Human Resources Officer
Wilkinson Peter J	0001398138	Apr-01-2019	officer: SVP, Chief Accounting Officer
van der Vaart Sandra D	0001537208	Feb-15-2019	officer: SVP, Global General Counsel
Caveney Brian J	0001717915	Sep-25-2017	officer: SVP, Chief Medical Officer
Gary M. Huff	0001702387	Mar-29-2017	officer: CEO, LabCorp Diagnostics
Ratliff John D	0001575951	Oct-01-2016	officer: CEO, Covance Drug Development
Parham Richelle P	0001550078	Feb-08-2016	director
Keller Deborah L	0001352992	Jan-01-2016	officer: CEO, Covance Drug Development
Uthgenannt Lisa J	0001636456	Jan-01-2016	officer: Chief Human Resources Officer
BERBERIAN LANCE	0001102900	Mar-11-2015	officer: SVP, Chief Information Officer
HERRING JOSEPH L	0001229873	Feb-19-2015	officer: CEO of Covance Drug Division
Dodson Edward T	0001620889	Dec-03-2014	officer: SVP, Chief Accounting Officer
Kong Garheng	0001435183	Dec-02-2014	director
EISENBERG GLENN A	0001222831	Jun-16-2014	officer: Chief Financial Officer, EVP
Gilliland Dwight Gary	0001603769	Apr-01-2014	director
Schechter Adam H	0001376841	Apr-01-2013	director
NEUPERT PETER M	0001237566	Jan-01-2013	director
EBERTS F SAMUEL III	0001229291	Feb-09-2011	officer: Chief Legal Officer, Secretary
Boyle James T. Jr.	0001454748	Feb-09-2011	officer: EVP, Chief Operating Officer
Fonseca Lidia	0001454944	Feb-09-2011	officer: Chief Information Officer
Brecher Mark E	0001457713	Feb-09-2011	officer: Chief Medical Officer
COLES N ANTHONY	0001197018	Jan-03-2011	director
Conrad Andrew J	0001468757	Jul-26-2010	officer: EVP, Chief Scientific Officer
HARDISON DON M	0001209588	Sep-04-2007	officer: EVP, COO
Williams R Sanders	0001375347	May-16-2007	director
Cook Woodrow L	0001384992	Jan-01-2007	officer: EVP, Eastern Operations
Troub Allen W	0001384993	Jan-01-2007	officer: EVP, Western Operations
Walton Andrew Scott	0001384994	Jan-01-2007	officer: EVP & CIO
ANDERSON KERRII B	0001227159	May-17-2006	director
Miller Benjamin R	0001327701	Jun-03-2005	officer: EVP, Oncology Products & Serv
Hayes William B	0001320940	Mar-10-2005	officer: Sr. Vice President
Rubenstein Arthur H	0001299135	Aug-02-2004	director
Watson Craig M	0001290377	May-12-2004	director
MAC MAHON THOMAS P	0001168580	Feb-17-2004	director, officer: Chairman & CEO
KING DAVID P	0001275654	Jan-06-2004	officer: EVP, Strategic Planning
HAAS WILLIAM	0001275833	Jan-06-2004	officer: EVP, Sales & Marketing
STARK STEVAN R	0001168582	Aug-20-2003	officer: Executive Vice President
SMITH BRADFORD T	0001168583	Aug-05-2003	officer: EVP,Chief Legal Off,Secretary
WEIKEL M KEITH	0001193930	Jul-16-2003	director
POWELL JAMES B	0001044220	May-14-2003	director
BELINGARD JEAN LUC	0001200845	May-14-2003	director
MITTELSTAEDT ROBERT E JR	0001200847	May-14-2003	director
LANE WENDY E	0001200848	May-14-2003	director
WALLACE ANDREW G	0001201215	May-14-2003	director
LAI GOLDMAN MYLA	0001168581	May-02-2003	officer: EVP & Chief Scientific Officer
NOVAK RICHARD L	0001168585	May-02-2003	officer: EVP & COO
ELINGBURG WESLEY R	0001168584	Apr-03-2003	officer: EVP, CFO, and Treasurer

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by LABORATORY CORP OF AMERICA HOLDINGS

Filings	Format	Description	Filed/Effective	File/Film Number
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000920148-24-000099 (34 Act) Size: 7827 KB	Aug-02-2024	001-11353 241170263
8-K	Document	Current report filing Acc-no: 0000920148-24-000096 (34 Act) Size: 663 KB	Aug-01-2024	001-11353 241164180
8-K	Document	Current report filing Acc-no: 0000920148-24-000093 (34 Act) Size: 159 KB	Jul-25-2024	001-11353 241139790
8-K	Document	Current report filing Acc-no: 0000920148-24-000090 (34 Act) Size: 160 KB	Jul-01-2024	001-11353 241088519
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001127602-24-018228 ( Act) Size: 7 KB	Jun-10-2024
8-K	Document	Current report filing Acc-no: 0000920148-24-000087 (34 Act) Size: 2971 KB	Jun-04-2024	001-11353 241016095
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001193125-24-153236 (34 Act) Size: 14 KB	Jun-03-2024	001-11353 241015028
SD	Document	Acc-no: 0001193125-24-150149 (34 Act) Size: 18 KB	May-30-2024	001-11353 241003440
8-K	Document	Current report filing Acc-no: 0000920148-24-000085 (34 Act) Size: 158 KB	May-28-2024	001-11353 24986251
25-NSE	Document	Acc-no: 0000876661-24-000366 (34 Act) Size: 4 KB	May-20-2024	001-11353 24962611
S-8	Document	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0000920148-24-000083 (33 Act) Size: 178 KB	May-17-2024	333-279514 24961026
S-3ASR	Document	Automatic shelf registration statement of securities of well-known seasoned issuers Acc-no: 0001193125-24-141814 (33 Act) Size: 1298 KB	May-17-2024	333-279510 24960632
POSASR	Document	Post-effective Amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR Acc-no: 0001193125-24-141810 (33 Act) Size: 19 KB	May-17-2024	333-268472 24960553
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0000920148-24-000081 (33 Act) Size: 35 KB	May-17-2024	333-211324 24960350
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0000920148-24-000080 (33 Act) Size: 35 KB	May-17-2024	333-211323 24960325
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0000920148-24-000079 (33 Act) Size: 53 KB	May-17-2024	333-97745 24960222
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0000920148-24-000078 (33 Act) Size: 53 KB	May-17-2024	333-181107 24960209
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0000920148-24-000077 (33 Act) Size: 53 KB	May-17-2024	333-150704 24960198
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0000920148-24-000076 (33 Act) Size: 53 KB	May-17-2024	333-102602 24960181
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0000920148-24-000074 (33 Act) Size: 53 KB	May-17-2024	333-115905 24960114

Recent 20 filings. View all LABORATORY CORP OF AMERICA HOLDINGS filings

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

LABORATORY CORP OF AMERICA HOLDINGS overview
LABORATORY CORP OF AMERICA HOLDINGS job
LABORATORY CORP OF AMERICA HOLDINGS stock
LABORATORY CORP OF AMERICA HOLDINGS ownership
LABORATORY CORP OF AMERICA HOLDINGS CEO
LABORATORY CORP OF AMERICA HOLDINGS documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.